The expression levels of MicroRNA-26a and -24 turned out to be promising predictors of further clinical course in patients with glioblastoma 1).

1)
Sippl C, Teping F, Ketter R, Braun L, Tremmel L, Schulz-Schaeffer W, Oertel J, Urbschat S. The influence of distinct regulatory MicroRNAs of the p15/p16/RB1/E2F pathway on the clinical progression of glioblastoma. World Neurosurg. 2019 Jul 24. pii: S1878-8750(19)32040-6. doi: 10.1016/j.wneu.2019.07.134. [Epub ahead of print] PubMed PMID: 31351207.